Name: 글로벌 시장 동향
SKU: MD7246
Availability: InStock

보고서 요약(국문)

개요
전 세계 장 관리 시스템 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
장 관리 시스템(BMS)은 묽거나 반유동성 변을 보는, 거동이 불편하거나 누워 지내는 요실금 환자에게 사용되는 일시적인 대변 누출 방지 장치입니다. 또한, 심한 화상 환자의 배변 기능 관리, 생식기, 회음부 또는 항문 피부 이식편의 치유 촉진, 성형 수술 후 감염 관리에도 사용됩니다.
대변 실금 관리를 위한 장 관리 시스템은 다른 모든 대변 실금 관리 방법을 고려한 후에만 삽입해야 합니다. 장 관리 시스템 사용은 환자 치료를 담당하는 의료진과 협의하여 결정해야 하며, 감염 관리, 기기 관련 피부 손상 위험, 사생활 보호 및 존엄성, 사용 금기 사항 등을 고려한 환자에 대한 종합적인 평가를 거쳐야 합니다.

장 관리 시스템은 감염 확산을 예방하는 것 외에도 사타구니 부위에 위치한 소변 카테터, 정맥 카테터, 동맥 카테터의 대변 세균 오염을 방지하여 국소 및 전신 감염을 예방할 수 있습니다.
시장 동향: 성장 동인 및 제약 요인
기술 발전 및 신제품 출시 증가
장 관리 시스템의 기술 발전과 주요 업체들의 신제품 출시가 예측 기간 동안 시장 성장을 더욱 촉진할 것입니다.
예를 들어, 2023년 4월 NHS 재단 신탁 소유의 디지털 헬스케어 기업인 헬스콜(Health Call)은 방광 및 장 질환 환자를 위한 자가 의뢰 플랫폼을 출시하여 사용자가 주치의를 만나지 않고도 재단 웹사이트에서 서비스를 신청할 수 있도록 했습니다. 이 플랫폼은 도움과 지원을 요청하는 과정을 간소화하여 사용자가 정확하고 사실에 근거한 의뢰를 제공할 수 있도록 함으로써 의료기관에서 더 쉽게 분류할 수 있도록 합니다.
2023년에 출시된 이 플랫폼은 분류 과정을 크게 개선하고 의뢰 속도를 높여 환자들이 연중무휴 24시간 서비스를 이용할 수 있도록 했습니다. 또한, 의뢰에 대한 명확한 감사 추적 기능을 제공하고 처리 속도를 향상시킵니다. 기술은 방광 및 장 관리 분야에서 점점 더 중요한 역할을 하고 있으며, 9개의 NHS 의료기관에서 AI 기기를 시험 운영하고 있고, 영국 스타트업인 Motilent는 국립보건임상연구소(NICE)로부터 자금을 지원받았습니다.
더불어, 세계적인 장루 관리 제품 제조업체 중 하나인 Coloplast는 2022년 2월 싱가포르에서 최신 혁신 제품인 SenSura Mio를 출시했습니다. 싱가포르는 동남아시아 최초로 SenSura Mio를 출시한 국가로, 장루를 가진 사람들, 즉 장루 수술을 받고 현재 장루를 가지고 살아가는 사람들의 삶의 질을 향상시키는 것을 목표로 합니다.

또한, 염증성 장 질환의 유병률 증가, 고령 인구 증가, 다양한 장 관리 제품 출시, 최근 및 신규 잠재적 승인, 그리고 유리한 보험 급여 정책은 예측 기간 동안 시장 성장을 더욱 촉진할 것입니다.
시장 동향: 제약 요인
변실금에 대한 비침습적 임상 관리 선호. 현재 변실금은 침습적(수술적) 또는 비침습적 방법으로 관리할 수 있습니다. 표준적인 수술적 치료법에는 항문관 내 생체 재료 주입, 항문관 고주파 치료, 항문 근육 손상 수술적 복구, 천골 신경 자극, 인공 장 괄약근 삽입, 항문 괄약근 강화를 위한 근육 전위술, 그리고 장루 형성술이 포함됩니다. 이러한 치료법은 종종 장기간의 환자 재활을 필요로 하며, 매우 불편하고 심한 통증을 유발하기도 합니다.
또한, 인식 부족, 규제 문제, 그리고 부작용에 대한 우려도 예측 기간 동안 시장 성장률을 저해하는 요인입니다.

시장 세분화 분석
전 세계 장 관리 시스템 시장은 제품 유형, 적용 분야, 환자 유형, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문에서 인공항문 주머니는 시장 점유율의 약 41.2%를 차지했습니다.
인공항문 주머니는 제품 유형 부문에서 41.2%의 점유율을 차지했으며, 예측 기간 동안에도 시장을 주도할 것으로 예상됩니다. 인공항문 주머니는 복벽에 있는 구멍(스토마)을 통해 소화관에서 대변(변)을 모으는 플라스틱 주머니입니다. 의사는 인공항문 수술 후 스토마에 주머니를 부착합니다.
인공항문 주머니(스토마 백 또는 오스토미 백이라고도 함)는 신체에서 배설물을 모으는 데 사용되는 작고 방수되는 주머니입니다. 인공항문 수술이라고 하는 수술을 통해 대장(결장)과 복벽 사이에 스토마 또는 오스토미라는 구멍이 만들어집니다. 이는 배설물이 직장과 항문을 통해 결장을 거치는 대신 복벽의 개구부를 통해 배출될 수 있도록 합니다.
예를 들어, 2021년 12월 콜로플라스트(Coloplast)는 센서를 사용하여 인공항문 주머니 환자에게 누출을 경고하고 예방 방법을 알려주는 제품인 헤일로(Heylo)의 효과를 테스트하기 위한 임상 시험을 시작했습니다. 따라서 위에서 언급한 요인들이 예측 기간 동안 해당 부문의 성장을 견인할 것으로 예상됩니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 대장암 발병률 증가와 고령 인구 증가 등의 요인으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 또한, 환자 인식 제고, 장 관리 시스템 도입률 증가, 제품 개발 투자 증가, 우수한 의료 인프라, 개발된 제품에 대한 높은 수용도 등이 북미 지역의 시장 지배력을 뒷받침하는 주요 요인입니다.

예를 들어, 2023년 5월 하이델베르크 인근 바그하우젤에 위치한 의료 기술 전문 기업인 Advanced Medical Balloons GmbH(이전 Creative Balloons GmbH)는 중환자 치료 사업을 미국으로 확장한다고 발표했습니다.
이는 최근 미국 식품의약국(FDA)으로부터 혁신적인 카테터 시스템인 hygh-tec의 승인을 받은 데 따른 것입니다. 이 혁신적인 대변 관리 시스템인 hygh-tec은 중환자실에서 치료를 받는 환자에게 최대한의 밀봉 효과를 제공하고 대변 누출을 방지합니다.
또한, 2021년 7월 Trio Healthcare는 미국 전문 금융 회사인 SWK Holdings Corporation으로부터 2차 투자 유치에 성공했습니다. 총 약 1천만 달러에 달하는 이 투자금은 Trio의 연구 개발 및 제조를 지원하고, 세계 최초의 장루 백인 Genii™의 대규모 글로벌 출시를 위한 사업 확장에 사용될 예정입니다.
COVID-19 영향 분석
COVID-19는 장 관리 시스템에 상당한 영향을 미쳤습니다. 코로나19 팬데믹 발생으로 인해 코로나19 감염과 관련된 다른 건강 합병증도 증가했습니다. 2022년 1월에 발표된 코로나바이러스 역학 감시 데이터베이스(SECURE-IBD) 보고서에 따르면, 염증성 장 질환(IBD) 환자에서 코로나19의 부정적인 결과는 연령 및 기타 동반 질환과 관련이 있는 것으로 나타났습니다.
경쟁 환경
장 관리 시스템 시장의 주요 글로벌 업체로는 Becton, Dickinson and Company, Coloplast Pty Ltd., ConvaTec Group plc., B Braun SE., Consure Medical Pvt. Ltd., GBUK Group Ltd., Wellandmedical, Wellspect, ProSys International Ltd., Qufora 등이 있습니다.
주요 개발 사항
 2022년 4월, Microbiotica는 크론병 및 궤양성 대장염 재단의 염증성 장 질환 벤처 프로그램의 일환으로 염증성 장 질환 치료법 개발을 위한 프로젝트 자금을 지원받았습니다.  2021년 11월, 글로벌 헬스케어 기술 선도 기업인 메드트로닉(Medtronic plc)은 미국 식품의약국(FDA)으로부터 원격 내시경 검사 시스템인 필캠 스몰 보울 3(PillCam Small Bowel 3)에 대한 510(k) 승인을 받았다고 발표했습니다. 필캠 SB3 @HOME 프로그램은 메드트로닉의 필캠 기술과 아마존 물류를 결합하여 환자들이 집에서 편안하게 신속하고 정확한 검사 결과를 얻을 수 있도록 설계되었습니다.

 2021년 5월, 방광 및 장 기능 장애 치료를 위한 혁신적인 제품을 개발 및 상용화하는 글로벌 의료 기술 기업인 액소닉스(Axonics, Inc.)는 2세대 액소닉스 r-SNM 이식형 신경자극기(INS)와 스마트MRI 기술이 적용된 무선 환자 원격 제어 시스템에 대한 유럽 CE 마크 승인을 받았다고 발표했습니다.

보고서 구매 이유:

• 제품 유형, 적용 분야, 환자 유형, 최종 사용자 및 지역별 글로벌 장 관리 시스템 시장 세분화 현황을 시각화하고 주요 기업 및 주요 업체를 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.
• 모든 세그먼트를 포함한 장 관리 시스템 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.
글로벌 장 관리 시스템 시장 보고서는 약 69개의 표, 70개의 그림, 185페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Bowel Management Systems Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Bowel management systems (BMS) are temporary containment devices, indicated for bedridden or immobilised incontinent patients, with little or no bowel control, who have a liquid or semi-liquid stool. They are also indicated for patients with severe burns to manage their bowel function, promote healing of genital, perineal or anal skin grafts and maintain infection control following plastic surgery.
A bowel management system for the control of faecal incontinence should only be inserted once all other faecal incontinence management alternatives have been considered. The use of a bowel management system must be agreed upon with the medical team in charge of the patient’s care following a holistic assessment of
the patient which has taken into consideration: infection control, risk of device-related skin breakdown, privacy and dignity, and contraindications for use.
In addition to preventing the spread of infection, a bowel management system can potentially prevent faecal bacterial contamination of urinary, intravenous and arterial catheters located in the groin area, causing local and systemic infection.
Market Dynamics: Drivers and Restraints
Rise in the technological advancements and product launches
The rise in the advancements in bowel management systems and novel product launches by key players will further drive the market growth during the forecast period.
For instance, in April 2023, NHS foundation trust owned digital health company health call launched a self-referral platform for bladder and bowel issues, allowing users to self-refer to services from the trust website without seeing their GP. The platform simplifies the process of seeking help and support, allowing users to give precise, factual referrals that are easier to triage by the trust.
The platform launched in 2023, has significantly improved triage and sped up referrals, allowing patients to access the service 24/7. Th,e solution also provides a clear audit trail for referrals and speeds up the process. Technology is playing a growing role in bladder and bowel care, with AI devices being trailed by nine NHS trusts and UK start-up Motilent receiving funding from the National Institute for Health and Care Research.
Moreover, in February 2022, Coloplast, one of the world's leading manufacturers of stoma care products launched its latest product innovation, the SenSura Mio in Singapore this year. Singapore is the first country in Southeast Asia that launch SenSura Mio which aims to improve the quality of life of ostomates, or people who have gone through ostomy and are now living with stoma.
Furthermore, the rise in the prevalence of inflammatory bowel diseases, the increasing geriatric population, the launch of various bowel management products, recent and new potential approvals, and Favorable reimbursement policies, will further drive the market growth during the forecast period.
Market Dynamics: Restraint
Patient preference for non-invasive clinical management of Fecal incontinence. Currently, Fecal incontinence can be managed invasively (surgically) or non-invasively. Standard modes of surgical treatment include the injection of biomaterials into the anal canal, radiofrequency treatment of the anal canal, surgical repair of anal muscle injuries, sacral nerve stimulation, artificial bowel sphincter, muscle transposition to reinforce the anal sphincter and the creation of a stoma. These often require long-term patient rehabilitation and also it is highly inconvenient and even severely painful.
Also, lack of awareness, regulatory concerns, and concerned side effects are also the factors that hamper the market growth rate during the forecast period.
Segment Analysis
The global bowel management systems is segmented based on product type, application, patient type, end-user and region.
The colostomy bags from the product type segment accounted for approximately 41.2% of the market share
The colostomy bags from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. A colostomy bag is a plastic bag that collects faecal matter, also called stool or poop, from the digestive tract through an opening in the abdominal wall called a stoma. Doctors attach a bag to the stoma following a colostomy operation.
A colostomy bag, also called a stoma bag or ostomy bag, is a small, waterproof pouch used to collect waste from the body. During a surgical procedure known as a colostomy, an opening called a stoma or ostomy is formed between the large intestine (colon) and the abdominal wall. This allows waste products to be excreted through the opening in the abdominal wall rather than via the colon through the rectum and anus.
For instance, in December 2021, Coloplast launched a clinical trial to test the effect of its ostomy product, Heylo, a product that uses sensors to warn patients with colostomy bags about leakage and advise them about how to prevent it. Thus, the above-mentioned factors are expected to drive the growth of the studied segment during the forecast period.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to factors such as the rising prevalence of colorectal cancer and the growing geriatric population. Additionally, increased patient awareness, rising adoption rates of intestinal management systems, increasing investments in product development, excellently established healthcare infrastructure, and strong acceptance of developed products are some of the key factors ensuring the region's dominance.
For instance, in May 2023 Advanced Medical Balloons GmbH (formerly Creative Balloons GmbH), a specialist in medical technology from Waghaeusel near Heidelberg, stated that the company is expanding its intensive care business to the United States.
This is based on the approval which has recently been granted by the U.S. Food and Drug Administration (FDA) for their innovative catheter system hygh-tec. The novel faecal management system hygh-tec provides maximum seal and prevention of faecal leakage in patients receiving intensive care.
Moreover, in July 2021 Trio Healthcare secured a second round of funding from US specialist finance company, SWK Holdings Corporation. The funding, approximately $10m in total, will support Trio’s R&D and manufacturing as it scales up operations to support a large-scale global roll-out of Trio’s world-first stoma bag, GeniiTM
COVID-19 Impact Analysis
COVID 19 had a substantial impact on bowel management systems. Amidst the outbreak of the COVID-19 pandemic, there has been a rise in other health complications that rose with COVID-19 infections. According to a report by the surveillance epidemiology of coronavirus Under Research Exclusion (SECURE-IBD) database published in January 2022 mentioned that adverse COVID-19 outcomes were associated with age and other co-morbidities among patients with inflammatory bowel disease (IBD).
Competitive Landscape
The major global players in the bowel management systems market include Becton, Dickinson and Company, Coloplast Pty Ltd., ConvaTec Group plc., B Braun SE., Consure Medical Pvt. Ltd., GBUK Group Ltd., Wellandmedical, Wellspect, ProSys International Ltd Qufora and among others.
Key Developments
 In April 2022, Microbiotica received project funding from the crohn's and colitis foundation as a part of their inflammatory bowel disease ventures program for the development of therapies to treat inflammatory bowel disease.
 In November 2021, Medtronic plc, a global leader in healthcare technology, stated that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its PillCam Small Bowel 3 system for remote endoscopy procedures. The PillCam SB3 @HOME program combines Medtronic's PillCam technology with Amazon logistics, a combination intended to ensure both timely and accurate results for patients from the comfort of their homes.
 In May 2021, Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, stated European CE Mark approval of its second-generation Axonics r-SNM implantable neurostimulator (INS) and wireless patient remote control with SmartMRI technology.
Why Purchase the Report?
• To visualize the global bowel management systems market segmentation-based product type, application, patient type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development
• Excel data sheet with numerous data points of bowel management systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global bowel management systems market report would provide approximately 69 tables, 70 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Patient Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Rise in the technology advancements
4.1.1.2. Rise in the product launches by key players
4.1.2. Restraints
4.1.2.1. Long-term patient rehabilitation
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Colostomy Bags*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Irrigation Systems
7.4. Nerve Modulation Devices
7.5. Others
8. By Patient Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
8.1.2. Market Attractiveness Index, By Patient Type
8.2. Adults*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pediatric
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Spinal Cord Injury*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neurological Disorders
9.4. Multiple Sclerosis
9.5. Stroke
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers (ASCs)
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Coloplast Pty Ltd.
13.3. ConvaTec Group plc.
13.4. B Braun SE.
13.5. Consure Medical Pvt. Ltd.
13.6. GBUK Group Ltd.
13.7. Wellandmedical
13.8. Wellspect
13.9. ProSys International Ltd
13.10. Qufora
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Becton, Dickinson and Company, 4. Key Developments, Coloplast Pty Ltd., ConvaTec Group plc., B Braun SE., Consure Medical Pvt. Ltd., GBUK Group Ltd., Wellandmedical, Wellspect, ProSys International Ltd, Qufora

표 목록 (Tables)

List of Tables

Table 1 Global Bowel Management Systems Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Bowel Management Systems Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Bowel Management Systems Market Value, By Patient Type, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Bowel Management Systems Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Bowel Management Systems Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Bowel Management Systems Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Bowel Management Systems Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Bowel Management Systems Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Bowel Management Systems Market Value, By Application, 2021-2030 (US$ Million)

Table 10 Global Bowel Management Systems Market Value, By Patient Type, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Bowel Management Systems Market Value, By Patient Type, 2021-2030 (US$ Million)

Table 12 Global Bowel Management Systems Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Bowel Management Systems Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Bowel Management Systems Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Bowel Management Systems Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Bowel Management Systems Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Bowel Management Systems Market Value, By Application, 2021-2030 (US$ Million)

Table 18 North America Bowel Management Systems Market Value, By Patient Type, 2021-2030 (US$ Million)

Table 19 North America Bowel Management Systems Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Bowel Management Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Bowel Management Systems Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Bowel Management Systems Market Value, By Application, 2021-2030 (US$ Million)

Table 23 South America Bowel Management Systems Market Value, By Patient Type, 2021-2030 (US$ Million)

Table 24 South America Bowel Management Systems Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Bowel Management Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Bowel Management Systems Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Bowel Management Systems Market Value, By Application, 2021-2030 (US$ Million)

Table 28 Europe Bowel Management Systems Market Value, By Patient Type, 2021-2030 (US$ Million)

Table 29 Europe Bowel Management Systems Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Bowel Management Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Bowel Management Systems Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Bowel Management Systems Market Value, By Application, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Bowel Management Systems Market Value, By Patient Type, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Bowel Management Systems Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Bowel Management Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Bowel Management Systems Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Bowel Management Systems Market Value, By Application, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Bowel Management Systems Market Value, By Patient Type, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Bowel Management Systems Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 Becton, Dickinson and Company: Overview

Table 41 Becton, Dickinson and Company: Product Portfolio

Table 42 Becton, Dickinson and Company: Key Developments

Table 43 Coloplast Pty Ltd.: Overview

Table 44 Coloplast Pty Ltd.: Product Portfolio

Table 45 Coloplast Pty Ltd.: Key Developments

Table 46 ConvaTec Group plc.: Overview

Table 47 ConvaTec Group plc.: Product Portfolio

Table 48 ConvaTec Group plc.: Key Developments

Table 49 B Braun SE.: Overview

Table 50 B Braun SE.: Product Portfolio

Table 51 B Braun SE.: Key Developments

Table 52 Consure Medical Pvt. Ltd.: Overview

Table 53 Consure Medical Pvt. Ltd.: Product Portfolio

Table 54 Consure Medical Pvt. Ltd.: Key Developments

Table 55 GBUK Group Ltd.: Overview

Table 56 GBUK Group Ltd.: Product Portfolio

Table 57 GBUK Group Ltd.: Key Developments

Table 58 Wellandmedical: Overview

Table 59 Wellandmedical: Product Portfolio

Table 60 Wellandmedical: Key Developments

Table 61 Wellspect: Overview

Table 62 Wellspect: Product Portfolio

Table 63 Wellspect: Key Developments

Table 64 ProSys International Ltd: Overview

Table 65 ProSys International Ltd: Product Portfolio

Table 66 ProSys International Ltd: Key Developments

Table 67 Qufora: Overview

Table 68 Qufora: Product Portfolio

Table 69 Qufora: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 2 Global Bowel Management Systems Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Bowel Management Systems Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Bowel Management Systems Market Share, By Patient Type, 2022 & 2030 (%)

Figure 5 Global Bowel Management Systems Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Bowel Management Systems Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Bowel Management Systems Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Colostomy Bags Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 9 Irrigation Systems Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 10 Nerve Modulation Devices Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 11 Others Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 12 Global Bowel Management Systems Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 13 Spinal Cord Injury Application in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 14 Neurological Disorders Application in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 15 Multiple Sclerosis Application in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 16 Stroke Application in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 17 Global Bowel Management Systems Market Y-o-Y Growth, By Patient Type, 2022-2030 (%)

Figure 18 Adults Patient Type in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 19 Pediatric Patient Type in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 20 Global Bowel Management Systems Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 21 Hospitals End-User in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 22 Ambulatory Surgical Centers End-User in Global Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 23 Other End-User in Global Bowel Management Systems Market Value, 2021-2030 (US Million)

Figure 24 Global Bowel Management Systems Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 25 North America Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 26 Asia-Pacific Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 27 Europe Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 28 South America Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 29 Middle East and Africa Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 30 North America Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 31 North America Bowel Management Systems Market Share, By Product Type, 2022 & 2030 (%)

Figure 32 North America Bowel Management Systems Market Share, By Application, 2022 & 2030 (%)

Figure 33 North America Bowel Management Systems Market Share, By Patient Type, 2022 & 2030 (%)

Figure 34 North America Bowel Management Systems Market Share, By End-User, 2022 & 2030 (%)

Figure 35 North America Bowel Management Systems Market Share, By Country, 2022 & 2030 (%)

Figure 36 South America Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 37 South America Bowel Management Systems Market Share, By Product Type, 2022 & 2030 (%)

Figure 38 South America Bowel Management Systems Market Share, By Application, 2022 & 2030 (%)

Figure 39 South America Bowel Management Systems Market Share, By Patient Type, 2022 & 2030 (%)

Figure 40 South America Bowel Management Systems Market Share, By End-User, 2022 & 2030 (%)

Figure 41 South America Bowel Management Systems Market Share, By Country, 2022 & 2030 (%)

Figure 42 Europe Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 43 Europe Bowel Management Systems Market Share, By Product Type, 2022 & 2030 (%)

Figure 44 Europe Bowel Management Systems Market Share, By Application, 2022 & 2030 (%)

Figure 45 Europe Bowel Management Systems Market Share, By Patient Type, 2022 & 2030 (%)

Figure 46 Europe Bowel Management Systems Market Share, By End-User, 2022 & 2030 (%)

Figure 47 Europe Bowel Management Systems Market Share, By Country, 2022 & 2030 (%)

Figure 48 Asia-Pacific Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 49 Asia-Pacific Bowel Management Systems Market Share, By Product Type, 2022 & 2030 (%)

Figure 50 Asia-Pacific Bowel Management Systems Market Share, By Application, 2022 & 2030 (%)

Figure 51 Asia-Pacific Bowel Management Systems Market Share, By Patient Type, 2022 & 2030 (%)

Figure 52 Asia-Pacific Bowel Management Systems Market Share, By End-User, 2022 & 2030 (%)

Figure 53 Asia-Pacific Bowel Management Systems Market Share, By Country, 2022 & 2030 (%)

Figure 54 Middle East & Africa Bowel Management Systems Market Value, 2021-2030 (US$ Million)

Figure 55 Middle East & Africa Bowel Management Systems Market Share, By Product Type, 2022 & 2030 (%)

Figure 56 Middle East & Africa Bowel Management Systems Market Share, By Application, 2022 & 2030 (%)

Figure 57 Middle East & Africa Bowel Management Systems Market Share, By Patient Type, 2022 & 2030 (%)

Figure 58 Middle East & Africa Bowel Management Systems Market Share, By End-User, 2022 & 2030 (%)

Figure 59 Becton, Dickinson and Company: Financials

Figure 60 Coloplast Pty Ltd.: Financials

Figure 61 ConvaTec Group plc.: Financials

Figure 62 B Braun SE.: Financials

Figure 63 Consure Medical Pvt. Ltd.: Financials

Figure 64 GBUK Group Ltd.: Financials

Figure 65 Wellandmedical: Financials

Figure 66 Wellspect: Financials

Figure 67 ProSys International Ltd: Financials

Figure 68 Qufora: Financials

글로벌 장 관리 시스템 시장 – 2023-2030

Global Bowel Management Systems Market -2023-2030